Lepu Biopharma names Ren Fangyuan employee representative supervisor, replacing Zhao Lixuan

• Lepu Biopharma replaced employee representative supervisor Zhao Lixuan, effective July 15, 2026.
• Ren Fangyuan took the role for the remainder of the current supervisory board term.
• Ren joined the group in August 2025, serves as an officer in the Securities Business Department.
• Ren holds a BSc in Finance from Concordia University, MSc in Finance from the University of Rochester.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12244806), on July 15, 2026, and is solely responsible for the information contained therein.